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ABSTRACT 
The aim of this research was to develop a novel lipid based film forming gel based on polymer and to investigate its potential as slow-release wound 
healing vehicle. The lipid based is composed of water soluble gel with model drug (Silver Sulfadiazine) and an egg oil, which acted as a remove scars. 
The morphology, rheology, mechanical properties, in-vitro drug release profiles were investigated. A smooth film layers was produced. The 
characterization results showed that film has superior mechanical and rheological properties than the ointment and cream. The lipid based gel 
treating low suppurating wounds and suitable for slow release application on wound surfaces. The lipid based gel also provided a significant higher 
healing rate in-vivo, with well-formed epidermis with faster granulation tissue formation when compared to the controls. In conclusions, a novel 
polymer-based lipid film gel was developed and results suggested that they can be exploited as slow-release wound dressings. 
Keywords: Wound healings, slow release, silver sulfadiazine and film gel 
INTRODUCTION 
Wound healing is defined as body’s replacement injured tissues with 
living tissues. It is a dynamic and intricate process which involve 
multiple cellular and matrix components act together to restore the 
integrity of injured tissue. The primary goals of wound care are 
rapid wound closure and leave minimal or aesthetically acceptable 
scar. Wound management is important in providing optimum 
healing milieu for wound healing [1,2]. Depending on the severity of 
the wound, the desirable wound dressing may therefore serve 
among the purposes of (a) to provide moisture and occlusion, (b) 
protection from infections and contamination, (c) debridement, and 
(d) easy application and removal avoiding dressing-related trauma 
[3, 4, 5]. Occasionally, drug-loaded wound dressings are used to treat 
wound locally such as anti-infections due to secondary infection or 
for pain control, especially in chronic wounds [6]. Various wound 
care products are available in the wound care management market 
and they are targeted towards the treatment of both acute and 
chronic wounds [5]. Among the modern wound dressings, dressings 
cast from hydrogels, have been developed and uses as the first major 
advances in moist wound management. Wound healing is promoted 
by dressings that maintain a moist environment. The formation of 
gel allows excess fluid to escape without permitting wound 
desiccation. 
Hydroxy Propyl Methyl Cellulose (HPMC), a natural polymer, is used 
in the fabrication of hydrocolloid film wound dressings due to its 
biocompatibility, biodegradation and excellent film forming 
properties. HPMC is a water-soluble. The various degree of cross-
linking will reduce significantly the hydrogels swelling in the 
presence of the water, causing the release of drugs within the 
matrices will be delayed. As a result, HPMC is often being exploited 
as a drug controlled release vehicle in drug delivery systems. As 
wound dressings HPMC gels can retain and create a moist 
environment around the wound to promote wound healing [7]. 
In this study, a lipid-based film formulation was developed and 
investigated for its potential as slow-release wound healing vehicle. 
A model drug (Silver Sulfadiazine) was loaded in lipid and dispersed 
in HPMC. Silver Sulfadiazine was chosen because it is used as an 
effective topical antimicrobial. The aim of this research was to 
develop a novel lipid based film forming gel to characterize 
rheological and mechanical properties. The surface and cross-
sectional morphology was examined in-vitro drug release was 
conducted using Franz diffusion cells. The key focus for such 
formulations with SSD would intend to prevent infection, decrease 
fluid imbalance, promote re-epithelialisation, and reduce the 
occurrence of pain and scar tissue in case of mild to severe burns 
and wounds. 
MATERIALS AND METHODS 
Materials 
Silver Sulfadiazine (purity 99%) was procured from Cipla 
pharmaceutical, Mumbai and Egg oil from VAV Life Science Pvt. Ltd. 
Mumbai, India. Hydroxy Propyl Methyl Cellulose (grade 1) (AR), 
Buffer Solution pH-7 (LR), Chloroform (LR), Di-methyl Sulphoxide 
(LR), Buffer Solution pH-4 (LR), Dichloromethane (AR) was 
purchased from Central Drug House (P) Ltd. New Delhi, India. 
Hydroxy Propyl Methyl Cellulose (grade 2)(LR) was purchased from 
E. Merck Ltd., Mumbai, India. Tween 80 (LR), Methyl paraben 
sodium (LR), Ammonia(25%) solution (LR), Polyethylene 
Glycol(PEGS)- 200 (LR), Benzyl Alcohol (LR), Glycerin (LR), Sodium 
Benzoate (LR), Triethanolamine (LR), Propylene Glycol (LR) was 
purchased from Thomas baker (chemicals) Pvt. Ltd. Mumbai, India. 
Carbopol 980 NF (LR) was obtained from Lubrizol and Octanol (AR) 
from Finar Reagent, Ahemdabad, India. All other chemicals and 
solvents were of analytical reagent grade. 
Methods 
Preformulation Studies 
Preformulation studies of the drug, excipients and their combination 
were carried out to determined the solubility, partition coefficient, 
Infra red spectroscopy etc. were carried out to determined the 
feasibility, possibility and solubility or the ingredients to develop the 
formulation and to determined compatibility. 
Partition Coefficient Determination 
Partition Coefficient was determined in n-octanol and water. Two 
solvents were mutually saturated before use, by shaking them 
together in equal volumes, for 24 h at 37o C or ambient temperature. 
With pure Silver Sulfadiazine after centrifugation at 2000 rpm for 20 
min, the n-octanol layer was pipetted out. A stock solution of drug 
was prepared in water. The drug stock solution (2 mL) and 
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saturated octanol (13 mL) were taken in a 25 mL conical flask that 
was capped tightly and shaken on a platform shaker for 24 h at 37 C 
at 80 horizontal stocks. The two liquids were than separated and 
analyzed for SSD content using the standard plot in distilled water. 
The partition/distribution coefficient was calculated according to 
the equation 
                         
    PC =                                                              Equation (1) 
Where,  
                     Co stands for concentration in oil phase 
Cw stands for concentration in aqueous phase 
Vw stands for volume of aqueous phase 
Vo stands for volume of oil phase 
Formulation Development 
The codes and composition of various gels prepared in the study are 
provided in table 2.1. 
 
Method of preparation  
The Silver sulphadiazine lipo-gels were formulated using different 
grades of  polymers and different ratio of drug: lipids 1:1, 1:2 and 
1:5. Unloaded gels were prepared in the same way except that Silver 
sulphadiazine was not added into the formulations. To formulate the 
gels, Silver sulphadiazine (1% w/w) was dispersed in known 
quantity of lipid in a beaker and mixed with Tween 80 and stirred 
until a viscous paste was obtained and stirring continuously 
followed by ultra-sonication for 20 min. This homogenous solution 
was obtained that was the lipoidal solution identified as solution ‘A’.  
In yet another beaker, measured volume of purified water was taken 
to which weighed quantities of Sodium Benzoate and Tween 80 
were added and dissolved. To this solution, required quantity of 
polymer was added using mechanical stirrer. A thick, viscous gel was 
formed that was identified as solution ‘B’. To this viscous gel B, all 
the contents of solution A were added as using mechanical stirrer 
into the vortex formed in solution. The mixture was stirred for 25 
min. followed by this, propylene Glycol, Poly ethylene glycol-200, 
Poly Ethylene Oxide (303), Ethanol was added into the formed gel. 
The total weight of the formulation was made up to 100 gm with 
purified water. Finally the pH of the gels was adjusted. The gels were 
kept in vacuum desiccators at room temperature to remove 
entrapped air over night. The final gel was filled in lacquered 
aluminum tubes and stored at room temperature. 
Table 2.1: Composition of gels prepared in the investigation 
Ingredients Formulation code & Quantities (%) 
B1 B2 B3 B4 B5 B6 B7 B8 B9 
Silver Sulphadiazine 1 1 1 1 1 1 1 1 1 
Lipids 5 5 2 5 1 1 2 2 1 
HPMC 15000 cps - - - 2 - - - 2 2 
Carbomer 2 - 2 - 2 - - - - 
HPMC 4000 cps - 2 - - - 2 2 - - 
Tween 80 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
Poly ethylene glycol-200 2 2 2 2 2 2 2 2 2 
Propylene Glycol 5 5 5 5 5 5 5 5 5 
Sodium Benzoate 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
Glycerin 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
Poly Ethylene Oxide(303) 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
Ethanol 10 10 10 10 10 10 10 10 10 
Purified Water (up to) 100 100 100 100 100 100 100 100 100 
 
Evaluation Parameters for the prepared formulation 
Visual appearance  
 
The prepared gels were visually inspected for clarity, color and 
transparency. 
 
Presence of particulate matter (grittiness) 
 
The prepared gels were evaluated for the presence of any particles. 
Smears of gels were prepared on glass slide and observed under the 
microscope for the presence of any particle or grittiness. 
 
pH of the gels 
 
The pH of gel was determined after diluting and dispersing it in 
distilled water (10% w/v). All the measurements were made in 
triplicate and mean calculated. 
 
Determination of Vesicle Size                                                                                               
                                                                                                                        
Optical microscopy was used for the determination of the vesicle 
size of the prepared formulation. The parameters observed were 
particle size, shape and presence of aggregates. 
 
Rheology of Gels  
 
Rheological studies of different formulations were performed at 
ambient temprature using a physical (MC-1) rheometer. The 
diameter of plate was 20.05 mm and cone angle was 1°. The 
interpolate    diameter   was   0.052 mm    and    truncation was 0.05'.  
 
Rheograms were produced in duplicate by gradually increasing the 
shear stress. The shear stress value was increased automatically by 
the instrument to a maximum value of 500 Pa over a period of 30 s.  
 
The relationship between shear stress and shear rate of each 
formulation was determined using Power law described in equation 
2.  
                                                          = k  n                                                                       
Equation-2 
All rheological analyses were performed in duplicate. Rheograms of 
optimized formulations by design was statistically evaluated by 
three way analysis of variance (ANOVA). 
in-vitro Permeation Studies 
 
This study was performed using Franz diffusion cell assembly. The 
jacketed cell embodied two limb reservoirs that involve a donor 
compartment, receptor compartment and a sampling port. The area 
of donor compartment exposed to receptor compartment, i.e. 
diffusion cross sectional area is 3.142 cm2, and the total capacity of 
the receptor compartment is 30 ml. The receptor medium is stirred 
throughout the study at 500 rpm employing a magnetic stirrer. The 
temperature of the receptor medium is maintained at 32±20C by 
circulating hot water in the outer jacket of cell employing a 
thermostatic water circulator. The release study carried out using 
diffusion membrane cut off range between 10000 to 14000Da.  
Prior to permeation experiment, membrane was clamped into donor 
and the receptor compartment of the jacketed vertical Franz 
diffusion cell. The receptor compartment was filled with distilled 
water pH 7.0. Silver sulphadiazine lipo-gel was applied on the 
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membrane at the donor cell of franz diffusion assembly having 1 gm 
drug. The donor chamber and sampling port were covered by para-
film to prevent evaporation during the study. Aliquots of 1ml are 
withdrawn periodically and replaced with equal volume of the 
receptor medium to maintain the receptor phase volume at constant 
level. Samples are suitable diluted and analyses for Silver 
sulphadiazine in UV spectroscopy at λmax 241 nm 
 
Treatment of dialysis tubing 
Dialysis tubing was treated before permeation studies as per 
procedure recommended by the supplier. The tubing was washed 
with running water for 3-4 h. to remove glycerin. The sulphur 
compounds were removed by treating the tubing with 0.3% w/v 
solution of sodium sulphide at 80o C for one minute. The tubing was 
subsequently washed with hot water (60oC) for two minutes, 
followed by acidification with a 0.2% v/v solution of sulphuric acid. 
Finally the tubing was rinsed with hot water to remove the acid. The 
treated tubing was kept in PBS 7.4 and refrigerated till use. Before 
use, the tubing was washed with distilled water and was cut open to 
expose maximum surface area 
.  
Figure 3.1: Franz diffusion cell 
Drug loading and entrapment efficiency 
Exactly 0.1g gel was completely dispersed in distilled water to make 
final volume 100 ml (0.1% w/v) by subjecting it to stirring (400 
rpm) for 5 min. The dispersion was than filtered to remove the 
undissolved residue. Exactly 1 ml of the filtrate was diluted to 5 ml 
and absorbance was measured at 241 nm. An unloaded gel was also 
subjected to a similar determination to observe the effect of 
excipients on the absorbance. Using the standard curve of Silver 
sulphadiazine in ammonia solution, the drug content in gel was 
finally estimated. Three batches of each polymer concentration were 
subjected to this determination. The percent encapsulation 
efficiency was determined using the following expression: 
Entrapment Efficiency (%) 
= 100
Content  Drug  lTheoretica
Content  Drug Actual  
  
Conformational stability of SSD in formulation by FTIR 
The conformational stability of SSD was determined by means of 
Fourier Transform Infra Red (FTIR) spectroscopy. The FTIR spectra 
of all formulations were obtained in the frequency range of 500 – 
4000 cm-1 and they were compared with FTIR spectra of pure SSD to 
assess any changes occurring to SSD on being formulated into a 
polymer solution. 
Stability Testing 
Physical stability testing 
The selected lipo-gel formulations were visually inspected everyday 
for seven weeks for any change in physical appearance of gels i.e., 
color, turbidity, odor etc. 
Chemical stability testing 
All the lipo- gels were subjected to stability studies by keeping them 
at accelerated conditions of temperature and humidity (40oC, 75% 
RH) for a period of 6 months. Zero time samples were used as 
controls. Lipo-gels packed in tubes as well as in plastic bottles were 
subjected to stability studies. Samples withdrawn at predetermined 
intervals (0, 1, 2 and 3 months) were analyzed for various 
performance parameters i.e., pH, rheology, microbial growth and 
drug content. Gels that failed in accelerated stability studies were 
stored at a temperature of 8-15oC (in a refrigerator).  Samples from 
these gels were withdrawn at predetermined intervals (0, 1, 2 and 3 
months) and analyzed for above mentioned performance 
parameters. These gels were also subjected to freeze-thaw study. In 
this study, samples were kept in refrigerator for 2 days followed by 
room temperature for two days. Five cycles were carried out and at 
the end, the performance parameters were determined. 
Containers for formulation 
According to USP XXII, containers including the closures for gels 
should not interact physically or chemically with the preparation in 
a manner to alter the strength of purity beyond the official 
requirements under ordinary or customary conditions of handling, 
shipment, storage, sale and use. Two types of containers were used 
in the study. Plastic bottles with wide mouth (3 cm diameter) and 
lacquered aluminum collapsible tubes were selected for the storage 
of gels. Aluminum collapsible tubes (20 g) were first washed with 
flowing tap water. They were subsequently washed with very mild 
detergent and again held under tap water to remove the detergent 
solution. They were then washed with purified water and dried in 
oven. Plastic closures were washed with tap water and with mild 
detergent solution. Later, they were thoroughly washed with 
purified water and dried at 40oC. Gels were filled in lacquered tubes 
and tubes were subsequently crimped. 
The aluminum collapsible tubes were tested for compliance with 
freedom from leakage and metal particles, as below: 
Freedom from Leakage  
Aluminum collapsible tubes (n=8) filled with the gel were placed in a 
horizontal position on a sheet of absorbent blotting paper in an oven 
maintained at 60 + 3oC for 8 h. After 8 h tubes were observed for 
leakage. 
Freedom from metal particles 
Aluminum collapsible tubes (n=8) filled with the gel were selected 
randomly. Smears of gels were prepared on glass slide and observed 
under microscope. 
RESULT AND DISCUSSION 
Preformulation Studies  
Physical characterization 








Silver Sulfadiazine pH-Solubility Profile 
 The solubility profile of Silver Sulfadiazine measured in various 
solvent. The lowest value for solubility 0.11mg/100ml was obtained 
in the water and the highest value of about 5.6 x 103mg/100ml was 
obtained in Nitric acid. 
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Table no. 3.2: Solubility Behaviour of Pure 
Silver Sulfadiazine Drug 
Solvent Solubility 
(mg/100ml) 




              2.2 x103 
Nitric acid                 5.6 x 103 
CONCLUSION 
From the above results solubility shown in table 3.2 indicates that 
Silver Sulfadiazine is insoluble in water and highest solubility seen in 
10% ammonia solution and Nitric acid. 
 Partition coefficient of Silver Sulfadiazine 
In order to assess the permeation of the drug, partition coefficient 
was determined at different pH.  
The log P value for a compound is the logarithm (base 10) of the 
partition coefficient (P), which is defined as the ratio of the 
compound’s organic (oil) to aqueous phase concentrations. The log P 
of a compound is constant for a given specific pair of aqueous and 
organic solvents. For example, a drug with a measured log P equal to 
1 indicates that its concentration is at a 10:1 ratio in organic to 
aqueous phase. The drug is hydrophobic and requires dissolution in 
an organic solvent. In contrast a drug with a log P value equal to –1 
indicates that the concentration is at a 1:10 ratio in organic to 
aqueous phase. This indicates that the drug is hydrophilic. A drug 
with a log P equal to 0 partitions at 1:1 ratio in organic to aqueous 
phase. The log P values of SSD with octanol/water system were 
found to be about 1, indicative of highly hydrophobic nature of SSD. 
The partition studies were performed in triplicate to ensure 
accuracy and reproducibility. The data obtained is shown in Table 
3.3. Results obtained were comparable with literature reports. 




Conc. in octanol 
(mg/mL) 
P Log p 
2.18 8.93 4.09 0.611 
Evaluation of Silver Sulfadiazine Gel 
 in-Vitro Permeability Release 
All the 9 formulations were subjected for the in vitro Permeability 
studies using Franz diffusion cell. The samples were withdrawn at 
ifferent time intervals and analyzed at 241 nm. Percentage 
Cumulative drug release was calculated on the basis of mean amount 
of silver sulfadiazine present in the respective gel. The results 
obtained in the in vitro drug release for the formulations B1 to B9 
are tabulated in Table 3.4 The plots are shown in Figure no. 3.1 for 
% cumulative drug release Vs time. 
 
Table 3.4: In-Vitro release Profile of silver sulfadiazine gel Formulations (B1 to B9) 
 
 
Figure 3.1: In-vitro Release Profile of Silver Sulfadiazine gel 
from Formulation batches (B1 To B9 ) 
The results are shown in Figure 3.1 indicate that the formulation, B4 
which was prepared by the HPMC (2%) and lipid (5%) with silver 
sulphadiazine showed good drug release after 8 hrs. Thus, the 
formulation (B4) has better result as comparison to others 
formulations. 
The mean % release of all formulation is presented in Table-3.4. The 
smallest mean % release of 27% was observed from Lipid based of 
Silver Sulfadiazine formulation B5 where as maximum % release 
was obtained as 98 % for B4 formulation. This indicates that at 
higher lipid concentration, the retention of gel is increased. So, the 
B4 formulation has 98.78% release 
 
 
Visual appearance  
All the nine hydrogels containing SSD were dispersed and found to 
be transparent and uniform in consistency. 
 
Figure: 3.2: gel base formulation of HPMC 4000cps, carbopol 
and HPMC 15000cps 
Presence of particulate matter   
All the nine formulations were evaluated microscopically for the 
presence of particulate matter. No appreciable particulate was seen 
in B7, B8 and B9 formulation under microscope. Hence, the gel 





% Cumulative drug release (Mean  SD) n= 3 
B1 B2 B3 B4 B5 B6 B7 B8 B9 
0 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
0.50 9.59±0.55 10.69±0.85 5.57±0.69 8.56±0.48 2.39±0.43 13.65±0.34 9.60±1.58 15.25±0.12 8.59±0.36 
1 13.21±0.38 37.89±0.28 21.98±0.84 16.98±0.24 5.62±0.21 26.48±0.51 15.49±2.01 19.87±0.98 21.65±0.56 
2 18.82±0.47 45.69±0.91 32.16±0.79 26.15±0.84 9.23±0.39 38.45±0.65 25.45±1.87 32.45±1.25 45.58±0.64 
4 23.23±0.28 67.87±0.72 36.66±1.06 55.26±0.53 15.23±0.45 56.98±0.21 41.84±1.25 45.89±0.43 51.29±0.23 
6 29.26±0.62 74.26±1.03 42.15±0.37 79.32±0.38 22.02±0.72 76.56±0.54 58.95±0.87 65.28±0.22 71.51±0.48 
8 38.36±0.58 89.78±0.95 52.26±1.02 98.78±0.31 27.71±0.49 92.35±0.48 75.88±0.41 79.25±2.22 85.65±0.89 
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The vesicle size of the prepared three batches of optimized 
formulation B7 was measured using optical microscopy as described 
above. The particles were found to be spherical, vesicular, multi 
lamellar and none aggregated. Particle size range from 20 to 400 µm. 
figure no. depicts a representative micrograph of optimized 
formulation. The results of vesicle size are shown in Table 3.5. 
 
Figure 3.3: Vesicles of Silver Sulfadiazine observed in optimized 
formulation 
Table 3.5: Vesicle size of the optimized formulation 





The mean vesicle sizes of all formulation are range in 45 μm to 159 
μm Formulation with same HPMC (15000cps) and sonicated at same 
time shows increase in vesicle size with respect to increase in lipid 
concentration. Though with decrease in lipid concentration the 
vesicular size also decreased, so the B4 formulation mean vesicle 
size is 77.58 μm 
Drug loading and entrapment efficiency  
Table 3.6 shows percent drug loaded and entrapment efficiency of 
optimized formulation. The optimized formulation offered good 
entrapment efficiency (89±0.66) and drug loading (6.15±0.66). The 
drug loading was based on polymer weight or total solid content of 
the formulation. The high entrapment efficiency of the particles may 
be attributed to the high polymer: drug ratio (1:1 in the present 
case), molecular weight of polymer, hydrophilicity of the polymer, 
viscosity of polymer and type of organic solvent used. High polymer 
content and high molecular weight of the polymer in the optimized 
formulations increase the viscosity of the formulation and exert 
pronounced molecular weight dependent attraction forces between 
polymer and lipid.  
    Table 3.6: Drug loading and entrapment efficiency of  
S. No. Drug Loading ( 




1 6.04 86 
2 6.26 93 
3 6.17 90 
mean 6.15±0.66 89±0.66 
3.2.6 In-vitro release of Optimized formulation 
The optimized formulation was prepared and their release study 
through cellophane membrane was studied. The optimized 
formulation showed near to 75% release in 8 hr. The release profile 
of optimized formulation is showed in Table 3.7 and graph is 
showed in Figure 3.4. 
Table 3.7: Release profile of Optimized formulation 










Figure 3.4: Release plot of optimized formulation 
Drug Release Kinetics Studies 
The drug release data of Silver Sulfadiazine were fitted to models 
representing zero order, first order, Higuchi’s, Hixson-crowell and 
Korsmeyer’s equation kinetics to know the release mechanisms. The 
data were processed for regression analysis using MS EXCEL 
statistical function. The results are shown in Table 3.8. 
Table 3.8: Equation of line and r2 values after fitting the release 
data to various models 
Model Formulation No.B4 
Zero order y = -8.674x + 96.92 R² = 0.988 
First order y =12.41x +2.602 R² = 0.995 
Higuchi y = 15.29x - 5.741 R² = 0.946 
Hixon-Crowell y = 0.187x + 0.009 R² = 0.973 
Peppas y = 0.315x - 1.020 R² = 0.985 
It was found that the in vitro drug release of optimize batch B4 was 
best explained by First order as the plots showed the highest 
linearity (R2 = 0.995). 
Rheology 
The rheology of the optimized formulation was measured. In the 
optimized formulation increasing the concentration of the polymer 
significantly increased the consistency. Increased consistency was 
ascribed to enhanced polymeric entanglements, thereby increasing 
the resistance to deformation. The formulations exhibited 
pseudoplastic flow; however no evidence of thixotropy was evident. 
Representative rheograms for optimized formulations are shown in 
figures 3.5 respectively. Application of the power law model to the 
rheological properties of each formulation enabled the calculation of 
the consistency (k) and flow index (n). The values of flow index (n) 
were found to be less than the optimized formulation confirming the 
shear thinning behavior of the gel. The same is also confirmed from 
viscosity vs. shear rate graphs.  
 
Figure 3.5: Rheogram of optimized formulation depicting power 
law 
Mehta et al. 





Figure 3.6: Plot of Viscosity vs. Shear rate for optimized 
formulation 
These figure 3.6 indicate that the viscosity of the system decreases 
with increase in shear rate. The formulation did not break even at 
shear rate of 500 indicating good gel strength. The values of flow 
index for optimized formulation was highest. High flow index 
reflects the mobility of the gel from the container. The values of 
consistency index for optimized formulation was found to be higher 
Infra-Red Spectroscopy 
The conformational stability of SSD was determined by means of 
Fourier Transform Infra Red (FTIR) spectroscopy. The FTIR spectra 
of all formulations were obtained in the frequency range of 500 – 
4000 cm-1. In Figure 3.7 the Infra red spectroscopy of Silver 
Sulfadiazine and in Figure 3.8 Infra red spectroscopy of Silver 
Sulfadiazine and HPMC gel are present and following peaks are 
interpret with Silver Sulfadiazine pure drug structure. 
Stability Testing 
Physical Stability 
The optimized formulation was visually inspected for everyday for 
first week and then was inspected at intervals of 1, 2 and 3 months 
respectively. The optimized formulation does not show any 
appreciable change in gel clarity and color ratifying physical stability 
of prepared optimized formulations. Further, no obnoxious odor was 
perceptible from formulation. However, the consistency of the 
optimized formulation was altered. 
 
Figure 3.7: Infra red spectroscopy of Silver Sulfadiazine 
Accelerated Stability Studies 
The optimized formulation was found to be stable at room 
temperature and at accelerated conditions (40oC+2oC, 
75%+5%RH). Even after exposure to heat and humidity, not much 
change was observed in pH of the gels Table 3.10. All other 
parameters were also observed to be comparable. The optimized 
formulation was then stored in refrigerator (8 to 15 C) and all the 
performance parameters were found to be comparable at each time 
point of the study. The results of freeze thaw study have been 
compiled in Table 3.11. The optimized formulation will be stable 
during that period 
 
Figure 3.8: Infra red spectroscopy of Silver Sulfadiazine and 
HPMC gel 
Functional Groups which are present in SSD are interpret with 
SSD+HPMC gel and following functional group in table- 3.9  
Table-3.9: Interpretation of FT-IR spectra of Silver 
Sulfadiazine+Hpmc gel 
 




2950-3000 cm-1 2982 cm-1 
N-H Stretch 
(Amines) 
3500-3300 cm-1 3333 cm-1 
S=O2 ≈1050 cm-1 1040cm-1 
C-N Stretch (Aryl) 1390-1250 cm-1 1383cm-1 
N-H Bend 
(Amines) 
1640-1500cm-1 1639 cm-1 
Table 3.10: various parameters noted in accelerated stability 
testing 
Gels  Optimized formulation 






Zero 7.0 None 98.68±0.25 
1 month 7.0 None 98.61±0.39 
2 month 7.0 None 98.64±0.21 
3 month 7.0 None 98.57±0.65 
Table 3.11: Results of Freeze Thaw studies conducted on 
optimized formulation 
Gels  Optimized formulation 






Zero 7.0 None 98.70±1.2 
1 month 7.0 None 98.61±0.41 
2 month 7.0 None 98.67±0.12 
3 month 7.0 None 98.65±0.26 
SUMMARY & CONCLUSION      
The formulation was selected as a lipo-structured carrier to deliver 
the Silver Sulfadiazine into systemic circulation through topical 
application. The evaluation of the formulation is dependent upon 
accurate results obtained by analytical method used during the 
study. Lipo-structured of Silver Sulfadiazine formulation were 
prepared with the lipid and hydrophilic polymers. All these 
polymers are generally recommended as safe by FDA. The 
formulation was optimized by using vesicle size, in-vitro 
permeability and rheology.. Different literature review was selected. 
Through this the effect of lipid and polymer on the response i.e. 
vesicle size, viscosity and % release studied. 
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It was found that the increase in lipid concentration decrease the 
viscosity but it also increases the size of the vesicle. Viscosity was 
found to be decrease with the increase in the lipid and drug 
concentration. The optimized formulation has the minimum vesicle 
size and enough viscosity. The % release of the optimized 
formulation was also found to be 98% in 8 hr. The lipo-structured 
based Silver Sulfadiazine formulation was prepared with good 
spread ability, strength, and extrusion from the container. The drug 
content of the formulations was found to be within the limits. 
Increasing the concentration of the polymer significantly increased 
the consistency. The formulation exhibited pseudo plastic flow with 
no thixotropy. The values of flow index (n) were found to be less of 
the optimized formulation confirming the shear thinning behaviour 
of the gel. 
The optimized formulation was found to be stable at accelerated 
stability conditions. Even after exposure to heat and humidity, no 
significant change was observed in the content uniformity, pH, 
clarity, and rheological properties of the gels. All other parameters 
were also observed to be comparable. When these gels were stored 
in refrigerator (8 to 15 °C), all the performance parameters were 
found to be comparable at each time point of the study. It could be 
concluded from freeze thaw study that optimized formulation was 
stable if they are stored in refrigerator. However, the formulation 
can be kept at room temperature for short periods of time if taken 
out for application.            
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